BSX vs. SNN

In the year-to-date period, BSX achieves a 56.46% return, which is significantly higher than SNN's -3.66% return. Over the past 10 years, BSX has outperformed SNN with an annualized return of 21.53%, while SNN has yielded a comparatively lower -0.86% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and Smith & Nephew plc (SNN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BSX Sharpe Ratio is 3.92, which is higher than the SNN Sharpe Ratio of 0.11. The chart below compares the historical Sharpe Ratios of BSX and SNN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BSX has not paid dividends to shareholders, while SNN's dividend yield for the trailing twelve months is around 2.94%.

The maximum BSX drawdown since its inception was -89.15%, which is greater than SNN's maximum drawdown of -55.20%. Use the drawdown chart below to compare losses from any high point for BSX and SNN. For additional features, visit the drawdowns tool.

The current volatility for Boston Scientific Corporation (BSX) is 5.84%, while Smith & Nephew plc (SNN) has a volatility of 15.88%. This indicates that BSX experiences smaller price fluctuations and is considered to be less risky than SNN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Boston Scientific Corporation and Smith & Nephew plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.